CelLBxHealth PLC (OTCPK:ANPCF)

Full Year 2025 Cellbxhealth PLC Earnings Call Transcript

Jun 22, 2026 / 10:00 AM GMT

Release Date Price: $0.0199

Transcript

Key Points

Positve

CelLBxHealth PLC (ANPCF) has established key partnerships, including a master service agreement with AstraZeneca and clinical studies with Advent Health, enhancing its market presence.
The company has achieved significant cost savings, reducing annualized cash operating costs by over 6.6 million, and has streamlined operations by consolidating into one site.
CelLBxHealth PLC (ANPCF) is well-positioned in the growing market for precision cancer diagnostics, with a projected market opportunity of over 1 billion by 2031.
The company has a strong patent portfolio and a validated platform with over 120 peer-reviewed publications, supporting its credibility in the oncology space.
CelLBxHealth PLC (ANPCF) has a new management team with strong commercial and clinical experience, focused on delivering revenue and profitability.

Negative

The company reported a decrease in revenues from 2.9 million in 2024 to 1.4 million in 2025, indicating challenging market conditions and slower commercial conversion.
CelLBxHealth PLC (ANPCF) experienced an operating loss of 19.2 million, with significant restructuring costs impacting financial performance.
The company faces challenges in generating clinical utility data, which is crucial for establishing the commercial viability of its CTC platform.
There is uncertainty regarding the long-term commercial value of the company's biobank samples, as current resources do not support extensive development of proprietary tests.
CelLBxHealth PLC (ANPCF) will require additional funding by Q2 2027, highlighting the need for successful revenue generation and strategic partnerships to ensure financial sustainability.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CLBX.L - Cellbxhealth PLC
Full Year 2025 Cellbxhealth PLC Earnings Call
Jun 22, 2026 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to the CellBX Health PLC investor presentation. Throughout this recorded presentation, investors will be in listen-only mode. Questions are encouraged and can be submitted at any time via the Q&A tab situated on the right-hand corner of your screen. Just simply type in your questions and press send. Before we begin, I'd like to submit the following poll. And I'd like to hand you over to Peter Collins, CEO. Good morning, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Good morning, everybody. Peter Collins, CEO at CellBX Health.

I

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.